Patients With Chronic Liver Disease Suggestive of Nonalcoholic Fatty Liver Disease May Be at Higher Risk for Drug-Induced Liver Injury.
Alanine Transaminase
/ blood
Alkaline Phosphatase
/ blood
Bilirubin
/ blood
Case-Control Studies
Cefazolin
Chemical and Drug Induced Liver Injury
/ etiology
Cohort Studies
Female
Humans
Liver Transplantation
/ statistics & numerical data
Male
Middle Aged
Non-alcoholic Fatty Liver Disease
/ blood
Risk Assessment
Journal
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
ISSN: 1542-7714
Titre abrégé: Clin Gastroenterol Hepatol
Pays: United States
ID NLM: 101160775
Informations de publication
Date de publication:
12 2019
12 2019
Historique:
received:
02
10
2018
revised:
08
12
2018
accepted:
12
12
2018
pubmed:
24
12
2018
medline:
28
10
2020
entrez:
24
12
2018
Statut:
ppublish
Résumé
To date, there have been no studies that systematically examined if individuals with nonalcoholic fatty liver disease (NAFLD) have an increased risk of drug-induced liver injury (DILI). We conducted a study to test if the frequency of suspected DILI from prescription agents is higher in individuals with chronic liver disease (CLD) suggestive of NAFLD.
Identifiants
pubmed: 30580093
pii: S1542-3565(18)31389-2
doi: 10.1016/j.cgh.2018.12.013
pii:
doi:
Substances chimiques
Alanine Transaminase
EC 2.6.1.2
Alkaline Phosphatase
EC 3.1.3.1
Cefazolin
IHS69L0Y4T
Bilirubin
RFM9X3LJ49
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2814-2815Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.